View in EDS HTML Full Text PDF Full Text

Extracellular vesicles in TDP-43 proteinopathies: pathogenesis and biomarker potential.

Saved in:
Bibliographic Details
Title: Extracellular vesicles in TDP-43 proteinopathies: pathogenesis and biomarker potential.
Authors: Dellar ER; Nuffield Department of Clinical Neurosciences, University of Oxford, Level 6, West Wing John Radcliffe Hospital, OX3 9DU, Oxford, UK., Nikel L; Nuffield Department of Clinical Neurosciences, University of Oxford, Level 6, West Wing John Radcliffe Hospital, OX3 9DU, Oxford, UK.; Kavli Institute for Nanoscience Discovery, University of Oxford, Dorothy Crowfoot Hodgkin Building, Oxford, UK., Fowler S; Oxford-GSK Institute of Molecular and Computational Medicine, University of Oxford, Oxford, UK.; Institute of Neurology, University College London, London, UK., Vahsen BF; Nuffield Department of Clinical Neurosciences, University of Oxford, Level 6, West Wing John Radcliffe Hospital, OX3 9DU, Oxford, UK.; Kavli Institute for Nanoscience Discovery, University of Oxford, Dorothy Crowfoot Hodgkin Building, Oxford, UK., Dafinca R; Nuffield Department of Clinical Neurosciences, University of Oxford, Level 6, West Wing John Radcliffe Hospital, OX3 9DU, Oxford, UK.; Kavli Institute for Nanoscience Discovery, University of Oxford, Dorothy Crowfoot Hodgkin Building, Oxford, UK., Feneberg E; Department of Neurology, Technical University of Munich School of Medicine and Health, Munich, Germany., Talbot K; Nuffield Department of Clinical Neurosciences, University of Oxford, Level 6, West Wing John Radcliffe Hospital, OX3 9DU, Oxford, UK.; Kavli Institute for Nanoscience Discovery, University of Oxford, Dorothy Crowfoot Hodgkin Building, Oxford, UK., Turner MR; Nuffield Department of Clinical Neurosciences, University of Oxford, Level 6, West Wing John Radcliffe Hospital, OX3 9DU, Oxford, UK., Thompson AG; Nuffield Department of Clinical Neurosciences, University of Oxford, Level 6, West Wing John Radcliffe Hospital, OX3 9DU, Oxford, UK. alexander.thompson@ndcn.ox.ac.uk.
Source: Molecular neurodegeneration [Mol Neurodegener] 2025 Jun 10; Vol. 20 (1), pp. 68. Date of Electronic Publication: 2025 Jun 10.
Publication Type: Journal Article; Review
Journal Info: Publisher: BioMed Central Country of Publication: England NLM ID: 101266600 Publication Model: Electronic Cited Medium: Internet ISSN: 1750-1326 (Electronic) Linking ISSN: 17501326 NLM ISO Abbreviation: Mol Neurodegener Subsets: MEDLINE; In Process
Database: MEDLINE Ultimate
Full text is not displayed to guests.
FullText Links:
  – Type: pdflink
Text:
  Availability: 1
Header DbId: mdl
DbLabel: MEDLINE Ultimate
An: 40495245
AccessLevel: 2
PubType: Academic Journal
PubTypeId: academicJournal
PreciseRelevancyScore: 0
IllustrationInfo
Items – Name: Title
  Label: Title
  Group: Ti
  Data: Extracellular vesicles in TDP-43 proteinopathies: pathogenesis and biomarker potential.
– Name: Author
  Label: Authors
  Group: Au
  Data: <searchLink fieldCode="AU" term="%22Dellar+ER%22">Dellar ER</searchLink>; Nuffield Department of Clinical Neurosciences, University of Oxford, Level 6, West Wing John Radcliffe Hospital, OX3 9DU, Oxford, UK.<br /><searchLink fieldCode="AU" term="%22Nikel+L%22">Nikel L</searchLink>; Nuffield Department of Clinical Neurosciences, University of Oxford, Level 6, West Wing John Radcliffe Hospital, OX3 9DU, Oxford, UK.; Kavli Institute for Nanoscience Discovery, University of Oxford, Dorothy Crowfoot Hodgkin Building, Oxford, UK.<br /><searchLink fieldCode="AU" term="%22Fowler+S%22">Fowler S</searchLink>; Oxford-GSK Institute of Molecular and Computational Medicine, University of Oxford, Oxford, UK.; Institute of Neurology, University College London, London, UK.<br /><searchLink fieldCode="AU" term="%22Vahsen+BF%22">Vahsen BF</searchLink>; Nuffield Department of Clinical Neurosciences, University of Oxford, Level 6, West Wing John Radcliffe Hospital, OX3 9DU, Oxford, UK.; Kavli Institute for Nanoscience Discovery, University of Oxford, Dorothy Crowfoot Hodgkin Building, Oxford, UK.<br /><searchLink fieldCode="AU" term="%22Dafinca+R%22">Dafinca R</searchLink>; Nuffield Department of Clinical Neurosciences, University of Oxford, Level 6, West Wing John Radcliffe Hospital, OX3 9DU, Oxford, UK.; Kavli Institute for Nanoscience Discovery, University of Oxford, Dorothy Crowfoot Hodgkin Building, Oxford, UK.<br /><searchLink fieldCode="AU" term="%22Feneberg+E%22">Feneberg E</searchLink>; Department of Neurology, Technical University of Munich School of Medicine and Health, Munich, Germany.<br /><searchLink fieldCode="AU" term="%22Talbot+K%22">Talbot K</searchLink>; Nuffield Department of Clinical Neurosciences, University of Oxford, Level 6, West Wing John Radcliffe Hospital, OX3 9DU, Oxford, UK.; Kavli Institute for Nanoscience Discovery, University of Oxford, Dorothy Crowfoot Hodgkin Building, Oxford, UK.<br /><searchLink fieldCode="AU" term="%22Turner+MR%22">Turner MR</searchLink>; Nuffield Department of Clinical Neurosciences, University of Oxford, Level 6, West Wing John Radcliffe Hospital, OX3 9DU, Oxford, UK.<br /><searchLink fieldCode="AU" term="%22Thompson+AG%22">Thompson AG</searchLink>; Nuffield Department of Clinical Neurosciences, University of Oxford, Level 6, West Wing John Radcliffe Hospital, OX3 9DU, Oxford, UK. alexander.thompson@ndcn.ox.ac.uk.
– Name: TitleSource
  Label: Source
  Group: Src
  Data: <searchLink fieldCode="JN" term="%22101266600%22">Molecular neurodegeneration</searchLink> [Mol Neurodegener] 2025 Jun 10; Vol. 20 (1), pp. 68. <i>Date of Electronic Publication: </i>2025 Jun 10.
– Name: TypePub
  Label: Publication Type
  Group: TypPub
  Data: Journal Article; Review
– Name: TitleSource
  Label: Journal Info
  Group: Src
  Data: <i>Publisher: </i><searchLink fieldCode="PB" term="%22BioMed+Central%22">BioMed Central </searchLink><i>Country of Publication: </i>England <i>NLM ID: </i>101266600 <i>Publication Model: </i>Electronic <i>Cited Medium: </i>Internet <i>ISSN: </i>1750-1326 (Electronic) <i>Linking ISSN: </i><searchLink fieldCode="IS" term="%2217501326%22">17501326 </searchLink><i>NLM ISO Abbreviation: </i>Mol Neurodegener <i>Subsets: </i>MEDLINE; In Process
PLink https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&db=mdl&AN=40495245
RecordInfo BibRecord:
  BibEntity:
    Identifiers:
      – Type: doi
        Value: 10.1186/s13024-025-00859-4
    Languages:
      – Code: eng
        Text: English
    PhysicalDescription:
      Pagination:
        StartPage: 68
    Titles:
      – TitleFull: Extracellular vesicles in TDP-43 proteinopathies: pathogenesis and biomarker potential.
        Type: main
  BibRelationships:
    HasContributorRelationships:
      – PersonEntity:
          Name:
            NameFull: Dellar ER
      – PersonEntity:
          Name:
            NameFull: Nikel L
      – PersonEntity:
          Name:
            NameFull: Fowler S
      – PersonEntity:
          Name:
            NameFull: Vahsen BF
      – PersonEntity:
          Name:
            NameFull: Dafinca R
      – PersonEntity:
          Name:
            NameFull: Feneberg E
      – PersonEntity:
          Name:
            NameFull: Talbot K
      – PersonEntity:
          Name:
            NameFull: Turner MR
      – PersonEntity:
          Name:
            NameFull: Thompson AG
    IsPartOfRelationships:
      – BibEntity:
          Dates:
            – D: 10
              M: 06
              Text: 2025 Jun 10
              Type: published
              Y: 2025
          Identifiers:
            – Type: issn-electronic
              Value: 1750-1326
          Numbering:
            – Type: volume
              Value: 20
            – Type: issue
              Value: 1
          Titles:
            – TitleFull: Molecular neurodegeneration
              Type: main
ResultId 1